Last Price
1.52
Today's Change
+0.48 (46.15%)
Day's Change
1.38 - 2.47
Trading Volume
206,001,303
Market Cap
259 Million
Shares Outstanding
170 Million
Avg Volume
6,023,760
Avg Price (50 Days)
0.52
Avg Price (200 Days)
2.92
PE Ratio
25.33
EPS
0.06
Earnings Announcement
27-May-2024
Previous Close
1.04
Open
1.49
Day's Range
1.38 - 2.47
Year Range
0.256 - 21.09
Trading Volume
206,024,308
1 Day Change
46.15%
5 Day Change
406.67%
1 Month Change
237.63%
3 Month Change
108.25%
6 Month Change
-33.62%
Ytd Change
-86.33%
1 Year Change
-85.99%
3 Year Change
-84.71%
5 Year Change
-84.71%
10 Year Change
-84.71%
Max Change
-84.71%
No result.
Sector: Healthcare - Healthcare
Industry: Biotechnology
Description:
Tevogen Bio Holdings Inc. operates as a clinical-stage biotechnology company that develops off-the-shelf precision T cell therapeutics in virology, oncology, and neurology. Its lead investigational precision T cell product, TVGN 489, is designed to address the unmet need of acute-risk COVID-19 patients, as well as a subset of patients suffering from long COVID. The company is based in Warren, New Jersey.